BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15068990)

  • 1. HIV survival benefit associated with earlier antiviral therapy.
    Mocroft A; Phillips AN; Lundgren JD
    Ann Intern Med; 2004 Apr; 140(7):578-9; author reply 579. PubMed ID: 15068990
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we be initiating antiretroviral therapy earlier? An argument in favour.
    Wood R
    S Afr Med J; 2005 Dec; 95(12):926, 928. PubMed ID: 16465350
    [No Abstract]   [Full Text] [Related]  

  • 3. Early versus deferred antiretroviral therapy for HIV.
    Hernán MA; Robins JM
    N Engl J Med; 2009 Aug; 361(8):822-3; author reply 823-4. PubMed ID: 19701984
    [No Abstract]   [Full Text] [Related]  

  • 4. Early versus deferred antiretroviral therapy for HIV.
    Buchbinder SP; Jain V
    N Engl J Med; 2009 Aug; 361(8):822; author reply 823-4. PubMed ID: 19692695
    [No Abstract]   [Full Text] [Related]  

  • 5. Getting smarter--the toxicity of undertreated HIV infection.
    Currier JS; Baden LR
    N Engl J Med; 2006 Nov; 355(22):2359-61. PubMed ID: 17135590
    [No Abstract]   [Full Text] [Related]  

  • 6. When to start antiretroviral therapy--ready when you are?
    Sax PE; Baden LR
    N Engl J Med; 2009 Apr; 360(18):1897-9. PubMed ID: 19339713
    [No Abstract]   [Full Text] [Related]  

  • 7. [Optimal time for antiretroviral therapy of HIV infection: NA-ACCORD (North American AIDS cohort collaboration on research and design)].
    Jensen B; Nitschmann S; Häussinger D
    Internist (Berl); 2009 Dec; 50(12):1425-6. PubMed ID: 19902153
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment. Individual approach needed for co-infections.
    AIDS Policy Law; 2011 Dec; 27(1):1. PubMed ID: 22319816
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?
    Boulle A; Clayden P; Cohen K; Cohen T; Conradie F; Dong K; Geffen N; Grimwood A; Hurtado R; Kenyon C; Lawn S; Maartens G; Meintjes G; Mendelson M; Murray M; Rangaka M; Sanne I; Spencer D; Taljaard J; Variava E; Venter WD; Wilson D
    S Afr Med J; 2010 Sep; 100(9):566, 568, 570-1. PubMed ID: 20822639
    [No Abstract]   [Full Text] [Related]  

  • 10. When to start ART in Africa--an urgent research priority.
    De Cock KM; El-Sadr WM
    N Engl J Med; 2013 Mar; 368(10):886-9. PubMed ID: 23425131
    [No Abstract]   [Full Text] [Related]  

  • 11. If we can't get what we want, can we get what we need? optimizing use of antiretroviral therapy in the current era.
    Baker JV; Henry K
    Ann Intern Med; 2011 Apr; 154(8):563-5. PubMed ID: 21502654
    [No Abstract]   [Full Text] [Related]  

  • 12. 2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
    Bucher HC; Wolbers M; Porter K
    JAMA; 2010 Nov; 304(17):1897; author reply 1897-8. PubMed ID: 21045094
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring of antiretroviral therapy in low-resource settings.
    Bendavid E
    Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700
    [No Abstract]   [Full Text] [Related]  

  • 14. [What happens when antiretroviral treatment is interrupted in clinical practice?].
    Marcos Sánchez F; Albo Castaño I; Joya Seijo D; del Valle Loarte P; Martín Barranco MJ
    An Med Interna; 2005 Oct; 22(10):502. PubMed ID: 16411308
    [No Abstract]   [Full Text] [Related]  

  • 15. Ending the HIV-AIDS Pandemic--Follow the Science.
    Fauci AS; Marston HD
    N Engl J Med; 2015 Dec; 373(23):2197-9. PubMed ID: 26624554
    [No Abstract]   [Full Text] [Related]  

  • 16. Co-trimoxazole, cART, and non-AIDS infectious diseases.
    Anglaret X; Eholie S
    Lancet; 2010 Apr; 375(9722):1231-3. PubMed ID: 20347482
    [No Abstract]   [Full Text] [Related]  

  • 17. Timing of antiretroviral drugs during tuberculosis therapy.
    Kadhiravan T
    N Engl J Med; 2010 Jun; 362(22):2138; author reply 2138-9. PubMed ID: 20527060
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question.
    Eholié SP; Badje A; Kouame GM; N'takpe JB; Moh R; Danel C; Anglaret X
    AIDS Res Ther; 2016; 13():27. PubMed ID: 27462361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early versus deferred antiretroviral therapy for HIV.
    Gelinck LB; van der Ende ME
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701986
    [No Abstract]   [Full Text] [Related]  

  • 20. Early versus deferred antiretroviral therapy for HIV.
    Arribas JR; Mora M; Pascual-Pareja JF
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.